Follow
Tzen Szen Toh
Tzen Szen Toh
Wellcome Trust Clinical PhD Fellow, Wellcome Sanger Institute
Verified email at sanger.ac.uk - Homepage
Title
Cited by
Cited by
Year
Looking beyond the hype: Applied AI and machine learning in translational medicine
TS Toh, F Dondelinger, D Wang
EBioMedicine 47, 607-615, 2019
1112019
Defining subpopulations of differential drug response to reveal novel target populations
N Keshava, TS Toh, H Yuan, B Yang, MP Menden, D Wang
NPJ systems biology and applications 5 (1), 36, 2019
252019
A statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimates
D Wang, J Hensman, G Kutkaite, TS Toh, A Galhoz, ...
Elife 9, e60352, 2020
212020
A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis
M Yan, S Sigurdson, N Greifer, TAC Kennedy, TS Toh, PE Lindsay, ...
Cancers 13 (12), 2895, 2021
122021
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre
M Yan, TS Toh, PE Lindsay, J Weiss, K Hueniken, C Yeung, V Sugumar, ...
Clinical and translational radiation oncology 30, 43-49, 2021
82021
Limited-Stage Small-Cell Lung Cancer: Current Progress and the Next Frontier
TS Toh, BH Lok
Radiation 1 (4), 317-333, 2021
2021
131: Limited-Stage Small Cell Lung Cancer: Outcomes Associated with Prophylactic Cranial Irradiation Over A 20-Year Period At A Single Institution
M Yan, TS Toh, P Lindsay, J Weiss, K Hueniken, V Sugumar, C Yeung, ...
Radiotherapy and Oncology 150, S57, 2020
2020
Outcomes of IMRT/VMAT vs 2D/3D-conformal thoracic radiation in limited stage small-cell lung cancer
TS Toh, A Bang, D Pinto, K Hueniken, C Brown, W Xu, G Liu, B Lok
Radiotherapy and Oncology 133, S399-S400, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–8